Immunologic and biophysical features of the BNT162b2 JN.1 and KP.2 adapted COVID-19 vaccines
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Researchers have conducted preclinical characterization of adapted covid-19 vaccines, including the BNT162b2 JN.1 and KP.2. The vaccines are adapted to address the Omicron XBB.1.5 variant. The study examines the immunologic and biophysical features of these adapted vaccines.